Abstract
Introduction: The aim of this study is to
investigate the relationship between the radiation
dose to pelvic and para-aortic lymph nodes, nodal
response, and clinical outcomes in a resource-poor
setting based on computed tomography (CT) nodal
size alone. Materials and Methods: This
retrospective study from 2009 to 2015 included 46
cervical cancer patients with 133 metastatic
pelvic and para-aortic lymph nodes definitively
treated with chemoradiation and brachytherapy in a
public hospital with limited access to positron
emission tomography (PET) scans. Hence, short axis
of the lymph node on CT scan was used as a measure
of metastatic nodal disease, before and following
radiation therapy. Inclusion criteria required the
pelvic and para-aortic nodes to have the shortest
axis diameter on CT scan of ≥8 mm and ≥10 mm,
respectively. Based on PET resolution, a node that
decreased to half of its inclusion cutoff size was
considered to have a complete response (CR).
Relevant clinical outcomes were documented and
correlated with nodal features, nodal radiation
doses, and treatment characteristics. Results:
After controlling for other predictive factors,
increased nodal dose was associated with increased
probability of CR per study definition (P =
0.005). However, there was no statistically
significant association between dose and
pelvic/para-aortic, distant and total recurrence
(TR), and any recurrence at any location (P =
0.263, 0.785, 1.00, respectively). Patients who
had no CR nodes had shorter pelvic/para-aortic
recurrence-free survival (PPRFS) and TR-free
survival (TRFS) than patients who had at least one
CR node (P = 0.027 and 0.046, respectively).
Patients with no CR nodes also had shorter PPRFS
than patients who had all nodes completely respond
(P < 0.05). Conclusions: Using CT-based
measures, we found that increased nodal dose is
associated with an increased probability of CR (as
defined) and nodal CR is associated with increased
PPRFS and TRFS. We were unable to determine the
cutoff dose required for a CR.